As effective inhibitors of MBL and the lectin pathway are already available for prophylactic treatment of CIN in humans, there is a need of additional animal and human studies to fully elucidate the role of MBL in the pathogenesis of CIN. This evidence concerns the gene MBL2 and cervical squamous intraepithelial neoplasia.